The Pharmacological Treatment of Hyperglycemia in NIDDM

A comprehensive examination by a panel of experts of a scientific or medical issue related to diabetes mellitus. A consensus conference is convened for the purpose of presenting expert opinion on an issue from which a consensus statement is developed. The statement represents the panel's collective analysis, evaluation, and opinion. The Consensus Statement is published in ADA journals and other scientific/medical journals, as appropriate. Once written by the panel, a Consensus Statement is not subject to subsequent review or approval and does not represent official association opinion.

[1]  G Dailey,et al.  Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[2]  R. DeFronzo,et al.  Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. , 1995, The New England journal of medicine.

[3]  G. Bray,et al.  Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. , 1995, The American journal of medicine.

[4]  P. J. Berry.  United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years , 1995, BMJ.

[5]  S. Ross,et al.  The Efficacy of Acarbose in the Treatment of Patients with NonInsulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial , 1994, Annals of Internal Medicine.

[6]  H. Arnqvist,et al.  Long-Term Improvement of Glycemic Control by Insulin Treatment in NIDDM Patients With Secondary Failure , 1994, Diabetes Care.

[7]  T. Buchanan,et al.  Insulin and hypertension: Are they related? , 1993, Steroids.

[8]  N. Hotta,et al.  The Effect of Acarbose on Blood Glucose Profiles of Type 2 Diabetic Patients Receiving Insulin Therapy , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[9]  B. Frier,et al.  Frequency and Symptoms of Hypoglycaemia Experienced by Patients with Type 2 Diabetes Treated with Insulin , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[10]  R. Henry,et al.  Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trial , 1993, Diabetes Care.

[11]  L. Niskanen,et al.  Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. , 1992, The New England journal of medicine.

[12]  G. Schernthaner,et al.  The Effect of Insulin Treatment on HbA1c, Body Weight and Lipids in Type 2 Diabetic Patients with Secondary-Failure to Sulfonylureas. , 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[13]  S. Haffner,et al.  The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. , 1992, American journal of epidemiology.

[14]  S. Genuth.  Management of the adult onset diabetic with sulfonylurea drug failure. , 1992, Endocrinology and metabolism clinics of North America.

[15]  L. Groop.  Sulfonylureas in NIDDM , 1992, Diabetes Care.

[16]  H. Lebovitz.  Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors. , 1992, Drugs.

[17]  T. Koschinsky,et al.  Oral antidiabetic combination therapy with sulphonylureas and metformin. , 1991, Diabete & metabolisme.

[18]  L. S. Hermann,et al.  Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus. , 1991, Diabete & metabolisme.

[19]  D L DeMets,et al.  Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. , 1988, JAMA.

[20]  J. Godine,et al.  Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study. , 1988, Annals of internal medicine.

[21]  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. , 1982, Diabetes.

[22]  A. Marble.  Oral hypoglycemic agents. , 1961, Annual review of medicine.